+Compare
PAVM
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
33.66M

PAVM PAVmed Forecast, Technical & Fundamental Analysis

a developer of medical devices

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for PAVM with price predictions
08:00 PM EDT Sep 28, 2023

PAVM in downward trend: price may decline as a result of having broken its higher Bollinger Band on September 01, 2023

PAVM broke above its upper Bollinger Band on September 01, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In of the 42 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PAVM moved out of overbought territory on September 12, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 18, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on PAVM as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PAVM turned negative on September 18, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

PAVM moved below its 50-day moving average on September 27, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PAVM crossed bearishly below the 50-day moving average on September 25, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PAVM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where PAVM advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 142 cases where PAVM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.174) is normal, around the industry mean (24.898). P/E Ratio (0.000) is within average values for comparable stocks, (79.320). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.382). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (37.175) is also within normal values, averaging (58.126).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PAVM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PAVM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.32B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 4%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -6%. FEMY experienced the highest price growth at 868%, while AVGR experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 137%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was 149%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 67
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

PAVM is expected to report earnings to fall 27.52% to -16 cents per share on November 14

PAVmed PAVM Stock Earnings Reports
Q3'23
Est.
$-0.17
Q2'23
Missed
by $0.05
Q1'23
Beat
by $0.11
Q4'22
Beat
by $0.02
Q3'22
Beat
by $0.12
The last earnings report on August 15 showed earnings per share of -23 cents, missing the estimate of -18 cents. With 146.80K shares outstanding, the current market capitalization sits at 33.66M.
A.I. Advisor
published General Information

General Information

a developer of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
360 Madison Avenue
Phone
+1 212 949-4319
Employees
124
Web
http://www.pavmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRKR0.940.11
+13.17%
36Kr Holdings
IBRX1.690.09
+5.62%
ImmunityBio
TRMR3.530.05
+1.44%
Tremor International Ltd
HUN24.400.20
+0.83%
Huntsman Corp
AMX17.320.10
+0.58%
America Movil SAB de CV

PAVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAVM has been loosely correlated with LUCD. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PAVM jumps, then LUCD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAVM
1D Price
Change %
PAVM100%
-2.55%
LUCD - PAVM
33%
Loosely correlated
-13.97%
CTSO - PAVM
30%
Poorly correlated
N/A
INMD - PAVM
28%
Poorly correlated
-1.58%
GMED - PAVM
27%
Poorly correlated
-1.19%
RGEN - PAVM
27%
Poorly correlated
-0.75%
More

Groups containing PAVM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAVM
1D Price
Change %
PAVM100%
-2.55%
Medical Specialties
(undefined stocks)
31%
Poorly correlated
+2.54%
Medical Specialties
(undefined stocks)
31%
Poorly correlated
+2.54%
medical research
(undefined stocks)
29%
Poorly correlated
-1.43%
medical service
(undefined stocks)
29%
Poorly correlated
-1.23%
medical devices
(undefined stocks)
26%
Poorly correlated
-1.09%